Take your read length, and multiply it by the number of bases to get the total bases present in your dataset. So for a 1M SE @ 50bp, you have 50Mb. For 1M PE @50bpx50bp, you have 100Mb. If you look at one PE file (reads1), then you get 50Mb. Note, that the bfast file will contain both PE in the same file, so that would be 100Mb.
Unconfigured Ad
Collapse
X
-
I'm sorry im still a little confused...Originally posted by nilshomer View PostTake your read length, and multiply it by the number of bases to get the total bases present in your dataset. So for a 1M SE @ 50bp, you have 50Mb. For 1M PE @50bpx50bp, you have 100Mb. If you look at one PE file (reads1), then you get 50Mb. Note, that the bfast file will contain both PE in the same file, so that would be 100Mb.
The formula i'm using for N is
N = (Genome size x Coverage) / ( RL1 + RL2)
So if my Genome size is 100Mb, Coverage is 10 and RL1 = RL2 = 50 (PE)
N = 100,000,000 x 10 / 100 = 10,000,000 read pairs
i.e *_10X_PE_1.fq = *_10x_PE_2.fq = 10,000,000 reads.
Now, if RL2=0, keeping coverage and genome size the same,
N = 100,000,000 x 10 / 50 = 20,000,000 read pairs or reads
i.e *_10X_SE_.fq1 = 20,000,000 reads and *_10X_SE_2.fq = 0 reads.
I Hope i'm right till here.
Furthermore, if i have already generated 20X coverage PE for the same genome,
N = 100,000,000 x 20 / 100 = 20,000,000 read pairs
i.e *_20X_PE_1.fq = *_20X_PE_2.fq = 20,000,000 reads.
Is it safe to assume that
either *_20X_PE_1.fq OR *_20X_PE_2.fq can be used as a substitute for *_10X_SE_.fq1 as both have the same number of reads?
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
Today, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 05:39 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Today, 05:39 AM
|
||
|
Started by SEQadmin2, Yesterday, 09:56 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
||
|
Started by SEQadmin2, 09-29-2026, 09:51 AM
|
0 responses
77 views
0 reactions
|
Last Post
by SEQadmin2
09-29-2026, 09:51 AM
|
Comment